Decoding IgA Nephropathy: From Suspicion to Solution
Jonathan Barratt, MD, PhD
Chee Kay Cheung, MBChB, MRCP, PhD
An De Vriese, MD, PhD
Jörg Latus, MD
Proteinuria in IgAN: The Signal, The Target, and the Treatment Goal
Navigating KDIGO Guidance in IgAN
Unmasking IgAN: Achieving Earlier Diagnosis
Mechanisms Matter! Optimizing Proteinuria Reduction In IgAN
CKD-aP Uncovered Prevalence & Pathophysiology
Steven Fishbane, MD
Nancy Helou, PhD
Spotlight on Assessment: Tools That Capture CKD-aP
Federico Alberici, MD, PhD
Anastasia Liossatou, PhD, RN
Winning the CKD-aP Battle: A United Physician-Nurse Front
Gabapentinoids: Safety Considerations and Downstream Outcomes
Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
Patrick Rossignol, MD, PhD
Julio Núñez, MD, PhD
Optimizing Iron Deficiency Management in CKD: IV Iron Replacement Therapy Amid the Latest KDIGO Guidelines
Brendon Neuen, MBBS, PhD
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
Antoine Lanot, MD, PhD
Gil Yosipovitch, MD
Inside the IgAN Clinic: Shared Decision-Making Into Practice
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
Ellie Kelepouris, MD, FACP, FAHA
Nihar R. Desai, MD, MPH
CKD-aP or Something Else? Decoding the Diagnosis
James Burton, DM, FRCP
Emilio Sanchez, MD, PhD
CKD-aP: Beyond the Surface
Leonie Kraft, MD
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Kidney Academy… but how about a more personalized experience?
Press cancel to remain on Global Kidney Academy. Press the link below or the continue button to keep going.